Nepal | July 14, 2020

Seasonal diseases claim 25 lives in Humla

Himalayan News Service
Share Now:

Humla, May 7

As many as 25 persons lost their lives in the past one month after seasonal diseases broke out in Humla district.

According to District Health Office, Humla seasonal diseases like common cold, cough and fever, among others, have affected five VDCs in the district.

Information Officer at DHO Naresh Shrestha said as many as 17 persons above the age of 64 years died of the diseases.

He said 10 persons died in Syada, seven persons in Raya, four in Shreenagar, and two each in Madana and Radikot VDCs. Shrestha said residents of all 27 VDCs of the district have been suffering from the diseases. Of the VDCs, Syada, Raya, Madana and Radikot VDCs have been the hardest hit.

It is said that a health workers’ team along with medicines have been providing door-to door services in the most affected areas since a week. “Dr Chhabi Bastola, Dr Anil Kumar Gupta and Dr Keashab Bhattarai-led health workers’ team have been treating patients in the villages,” added Shrestha.

It has been reported that a health workers’ team of World Health Organisation has taken the saliva, cough, blood samples from 16 patients for test.

“We will only know whether or not seasonal diseases are the cause of deaths after it submits a report,” said Shrestha.

Similarly, a lab team deployed from the Mid-western Regional Health Directorate, Surkhet has reached the most affected areas with needed medicines and equipment.

Meanwhile, Chief District Officer of Humla Dr Krishna Bahadur Ghimire said his office in coordination with the district health office has deployed health workers’ team along with medicines to the worst hit areas.

It is also said that the residents of Shreenagar have submitted a memorandum to the administration citing that seasonal diseases has begun to claim the lives of villagers.

A version of this article appears in print on May 08, 2016 of The Himalayan Times.

Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

Photo Gallery: Aerial view of Dharahara reconstruction site

Kathmandu, July 13 An aerial view of Dharahara tower being reconstructed, in Kathmandu, as seen on Monday, July 13, 2020. Read More...

Nepal’s COVID-19 tally reaches 16,945 with 144 new cases detected on Monday

KATHMANDU: The Ministry of Health and Population has reported 144 new cases of the coronavirus infection on Monday, which has taken the nationwide COVID-19 tally to 16,945. Of the newly infected, six persons are from Province 1; 41 from Province 2; 13 from Bagmati Province; eight from Gandaki Pro Read More...

Nepal COVID-19 Update: 144 new cases, 1,705 recoveries, no deaths recorded today

KATHMANDU: Nepal’s Health Ministry, in its regular press briefing, shared the latest updates on coronavirus contagion from across the country, and government’s response to the health crisis. As of today, 289,371 tests through Polymerase Chain Reaction (PCR) method have been carried out, Read More...

Nepal witnesses sharp spike in COVID-19 recovery cases on Monday

KATHMANDU: Nepal reported a sharp spike in daily recovery cases on Monday, logging the highest number of single-day Covid-19 recovery total in the country, till date. As many as 1,705 persons earlier diagnosed with the infection have been discharged from various health care facilities across the Read More...

Six found dead, six others still missing in Tanahun landslides

DAMAULI: Six persons were found dead while six others are still reported missing in landslides at assorted locations in Tanahun district. With the monsoon at it's peak, torrential rainfall-triggered landslips and floods swept away human settlement at  Bhaisekili in Rishing Rural Municipality Read More...

Google announces $10 billion 'digitization' fund for India

NEW DELHI: US tech giant Google is investing in a $10 billion fund to help accelerate India's transition to a digital economy in the next five to seven years. Sundar Pichai, CEO of Alphabet Inc's Google, said Monday that the project will focus on building products that are relevant to India's nee Read More...

Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status

LONDON: Two experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and US pharmaceutical giant Pfizer have received 'fast track' designation from the US drug regulator, the companies said on Monday. The candidates, BNT162b1 and BNT162b2, are the most advanced of the Read More...